David W. Russell

机构：Pfizer (United States) · ORCID：0000-0002-0277-403X

发表论文 866 篇 · 总被引 71467 次 · h-index 144

代表论文

• Engineering universal cells that evade immune detection (2019 · Nature reviews. Immunology · 被引 238)
• Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice (2020 · Molecular Therapy · 被引 108)
• Mechatronics in Action: Case Studies in Mechatronics - Applications and Education (2020 · DIAL (Catholic University of Leuven) · 被引 14)
• Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme, following administration of single and multiple doses to healthy volunteers (2021 · Alzheimer s & Dementia · 被引 9)
• Peripheral parenteral nutrition: A retrospective observational study to evaluate utility and complications (2024 · Nutrition in Clinical Practice · 被引 7)
• N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21 (2021 · Scientific Reports · 被引 7)